Replies to post #157301 on Biotech Values

[DewDiligence]

…that makes the editorial even funnier…. This does not mean that I think that drug pricing is reasonable - but it might be wise to avoid throwing rocks if you are an MD at Anderson.

I don’t see anything funny or ironic about the editorial. Hospital costs for the uninsured or underinsured at institutions such as MD Anderson may indeed be outrageous, but this has little to do with the problem addressed by the editorial: $100,000+ prices for cancer drugs that extend life very modestly.